TG and Graves disease: The current study is strengthened by including hypothyroid patients under LT4 monotherapy due to radioactive iodine intake for treating Graves’ Disease with no or negligible residual secretion of endogenous T3 and T4 and using the modern technique for measurement of thyroid hormones.